Escinum
important information for the patient.
This medicine should always be taken exactly as described in the patient leaflet or as directed by
the doctor or pharmacist.
Reparil is a medicine used for swelling after local injuries.
Before starting to take Reparil, the doctor or pharmacist should be consulted.
Kidney function should be monitored during treatment with the medicine.
Administration of the medicine to children under 7 years of age is contraindicated.
The doctor or pharmacist should be informed about all medicines the patient is taking or has recently taken, as well as any medicines the patient plans to take.
Reparil may enhance the effect of anticoagulant medicines.
Concomitant use of Reparil with aminoglycoside antibiotics should be avoided due to the possible increased toxic effect of these antibiotics on the kidneys.
Antibiotics such as cefalotin and ampicillin may increase the concentration of escin in serum, therefore, it is not recommended to administer these medicines concomitantly with Reparil.
Reparil should be taken after a meal. The tablet should be swallowed whole, with a glass of water.
If the patient is pregnant or breastfeeding, thinks she may be pregnant or is planning to have a baby, she should consult her doctor or pharmacist before taking this medicine.
Due to the lack of studies in pregnant women and insufficient data from animal studies, Reparil should not be used in pregnant women.
Due to the lack of data on the penetration of escin into breast milk, Reparil should not be used in breastfeeding women.
Reparil has no influence or negligible influence on the ability to drive and use machines.
If the patient has previously been diagnosed with intolerance to some sugars, the patient should consult the doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as described in the patient leaflet or as directed by the doctor or pharmacist. In case of doubt, the doctor or pharmacist should be consulted.
Unless the doctor has prescribed otherwise, Reparil should be taken as follows:
Reparil should be taken after a meal. The tablet should be swallowed whole, with a glass of water.
In case of taking a higher dose of the medicine than recommended, the doctor or pharmacist should be consulted immediately.
The next tablet should be taken as scheduled.
A double dose should not be taken to make up for a missed dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects may occur:
The following side effects have been reported:
In case of a hypersensitivity reaction, Reparil should be discontinued.
If any side effects occur, including any side effects not listed in the leaflet, the doctor or pharmacist should be informed. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al.
Jerozolimskie 181C, 02-222 Warsaw,
phone: + 48 22 49 21 301, fax: + 48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The pharmacist should be asked how to dispose of medicines no longer required. These measures will help protect the environment.
Al/PVC blisters in a cardboard box.
20 pieces - 2 blisters of 10 enteric-coated tablets
or
40 pieces - 4 blisters of 10 enteric-coated tablets
For more detailed information, the marketing authorization holder or parallel importer should be consulted.
Mylan Österreich GmbH
Guglgasse 15
1110 Vienna, Austria
MADAUS GmbH
D-51101 Cologne
Germany
Medezin Sp. z o.o.
Zbąszyńska 3 Street
91-342 Łódź
Medezin Sp. z o.o.
Zbąszyńska 3 Street
91-342 Łódź
Austrian marketing authorization number: 12.947
Parallel import authorization number: 58/20
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.